---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-002584"
form_type: "8-K"
ticker: "MLSS"
cik: "0000855683"
company_name: "MILESTONE SCIENTIFIC INC."
filed_at: "2023-02-06T23:59:59+00:00"
generated_at: "2026-06-20T00:39:39.189405+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Milestone Scientific appoints Peter Milligan as part-time CFO effective Feb 1, 2023

## Summary
- Annual salary of $120,000 plus incentive bonus target of 40% of cash compensation payable in shares.
- Eligible for $100,000 in annual restricted stock ($50k Feb 1, $50k Aug 1) valued at closing price, issued 60 days post-termination.
- Milligan previously CFO at Melinta Therapeutics (led through Chapter 11), Exelis, and senior finance roles at ITT and AT&T.

## SEC filing metadata
- accession: 0001437749-23-002584
- form_type: 8-K
- ticker: MLSS
- cik: 0000855683
- company_name: MILESTONE SCIENTIFIC INC.
- filed_at: 2023-02-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/855683/000143774923002584/0001437749-23-002584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/855683/000143774923002584/mlss20230206_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-002584
- JSON: https://secwatch.observer/filing/0001437749-23-002584.json
- Plain text: https://secwatch.observer/filing/0001437749-23-002584.txt

## Key facts
- Executive change
  Peter Milligan was appointed as Chief Financial Officer at MILESTONE SCIENTIFIC INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On February 6, 2023, Milestone Scientific Inc. (the “Company”) announced the appointment of Peter Milligan as the Company’s Chief Financial Officer, on a part-time basis, effective February1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/855683/000143774923002584/0001437749-23-002584-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.